Family business invests in start-up Bürkert Fluid Control Systems has taken a stake in Green Elephant Biotech as a strategic investor, so the two companies can work together to develop more efficient, flexible, and sustainable cell cultivation processes in the pharmaceutical and biotech industries. This partnership should enable more cost-effective production of therapeutics and facilitate […]
TG Therapeutics to use MaxCyte’s Flow Electroporation® technology and ExPERT™ platform to support the development and commercialization of azer-cel, its allogeneic CD19 CAR T cell therapy program, for the treatment of autoimmune diseases ROCKVILLE, Md. — MaxCyte, Inc., (Nasdaq: MXCT; LSE: MXCT), a leading, cell-engineering focused company providing enabling platform technologies to advance the discovery, […]
The Invitrogen™ EVOS™ S1000 Spatial Imaging System features intuitive software that empowers researchers to achieve more with their tissue samples while reducing sample processing time. WALTHAM, Mass. — Thermo Fisher Scientific Inc., the world leader in serving science, today introduced the Invitrogen™ EVOS™ S1000 Spatial Imaging System. This advanced system addresses the limitations of current […]
Recent technical progress has led the Board of Directors of Phase Holographic Imaging (PHI) to decide to focus resources on the company’s clinical product development program. In relation to this, the Board of Directors has, in discussion with CEO Anders Månsson, decided to initiate the search for a new CEO to lead the ambitious development […]
Investment Powers the Debut of Pyxa: A Groundbreaking Platform for 3D Spatial Biology Research BOSTON — Stellaromics, a pioneer in 3D spatial biology spun out of the laboratories of Karl Deisseroth (Stanford University) and Xiao Wang (MIT and Broad Institute), today announced the completion of a Series B funding round in the amount of $80M. […]
Seattle, WA – Pluristyx, the leading provider of innovative induced pluripotent stem cells (iPSC), announces the issuance of the groundbreaking induced Allogeneic Cell Tolerance (iACT Stealth™) U.S. Patent No. 12,178,835. This patent marks a significant milestone in Pluristyx’s mission to bring advanced cell therapy solutions to the global market. Additionally, patents for iACT Stealth™ have been issued or are […]
Tokyo, Japan and Toronto, Canada — PHC Corporation has signed a Master Collaboration Agreement with CCRM to work together on the development of primary T-cell(*1) expansion culture processes that will seek to accelerate the manufacturing of cell and gene therapy (CGT) products. This joint initiative will integrate “LiCellGrow™(*2), PHC’s cell expansion system under development, with CCRM’s […]
Landmark single-cell dataset of one billion cells will be used to train new AI models to advance researchers’ understanding of cellular behavior and gene function REDWOOD CITY, Calif. – Today, the Chan Zuckerberg Initiative (CZI) launched the Billion Cells Project, an effort to generate an unprecedented one billion cell dataset to fuel rapid progress in […]
Rapid menu expansion with new high-plex human and mouse neurobiology panels joining the recently launched Human IO60 and Mouse FFPE IO Panels The new offerings solidify leadership in spatial biology and broaden reach to new verticals MARLBOROUGH, Mass. — Akoya Biosciences, a spatial proteomics leader, announced its reagent product roadmap today, featuring new ultrahigh-plex neurobiology […]
Acquisition is the fourth for VION as it continues to expand its portfolio of proprietary products for life science research NASHVILLE, Tenn. — VION Biosciences, a life science platform company focused on specialty materials in the life science research, diagnostics, and drug discovery spaces, announced its January 2025 acquisition of San Francisco area-based BioAssay Systems, […]
Pay Invoice
Latest Blogs
-
EU Roadmap Provides Further Impetus for New Approach Methodologies
June 29, 2026 12:56 pm
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
-
Carterra Introduces Faster SPR
March 27, 2026 7:26 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
